May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Analysis of Recurrent Choroidal Neovascularization after Macular Translocation with 360° Retinotomy for Neovascular Age–related Macular Degeneration
Author Affiliations & Notes
  • F. Ziemssen
    Department I, University Eye Hospital Tübingen, Tuebingen, Germany
  • F. Gelisken
    Department I, University Eye Hospital Tübingen, Tuebingen, Germany
  • S. Grisanti
    Department I, University Eye Hospital Tübingen, Tuebingen, Germany
  • W. Inhoffen
    Department I, University Eye Hospital Tübingen, Tuebingen, Germany
  • K.–U. Bartz–Schmidt
    Department I, University Eye Hospital Tübingen, Tuebingen, Germany
  • Footnotes
    Commercial Relationships  F. Ziemssen, None; F. Gelisken, None; S. Grisanti, None; W. Inhoffen, None; K. Bartz–Schmidt, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 2002. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      F. Ziemssen, F. Gelisken, S. Grisanti, W. Inhoffen, K.–U. Bartz–Schmidt; Analysis of Recurrent Choroidal Neovascularization after Macular Translocation with 360° Retinotomy for Neovascular Age–related Macular Degeneration . Invest. Ophthalmol. Vis. Sci. 2004;45(13):2002.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To describe the functional and morphological outcome of recurrent choroidal neovascularization (CNV) after macular translocation (MT–360°) for neovascular age–related macular degeneration (AMD). Methods: This retrospective study includes all consecutive patients who underwent MT–360° for neovascular AMD between July 2001 and March 2003, with a follow–up of at least 6 months. All patients had subfoveal CNV lesion. Visual acuity examination was performed using a standardized protocol. Fundus photography and stereoscopic fluorescein angiography were performed preoperative and in three month intervals postoperatively. Initial lesion size, characteristics of recurrent CNV and treatment procedures were noted. Results: 30 eyes of 30 patients (16 women and 14 men, range in age 66–92 years) were analysed that fulfilled the inclusion criteria. The median follow–up was 19,5 months (range, 7–28 months). Preoperative size of the total lesion (CNV and other lesion components) was three Macular Photocoagulation Study disc areas (range, 1–14 disc areas). Six patients had extensive subretinal hemorrhage at the macula, three patients had pure occult or minimal classic CNV and 21 patients had classic or predominant classic CNV. The best–corrected visual acuity (logMAR score) improved from 0,90 (range 0,4 – 1,5) to 0,78 (range 0,2 – 1,3) at the last follow–up. 60% (18/30) of the eyes developed recurrent CNV. 83% (15/18) of the recurrent CNV was extrafoveal, 6% (1/18) showed juxtafoveal and 11% (2/18) subfoveal CNV, respectively. In this group, we found persistent or new recurrent CNV after initial treatment in 39% (7/18). 70% (19/27) of the recurrent CNV was treated by conventional laser photocoagulation and 15% (4/27) underwent photodynamic therapy Conclusions: In our study 60% of the eyes showed recurrent CNV after macular translocation for neovascular AMD in a mean follow–up of 19.5 months. Early treatment of recurrent CNV was associated with favourable visual prognosis. Since the majority of the recurrent CNV's after MT–360° were extrafoveal, regular follow–up examination with fluorescein angiography is recommended.

Keywords: age–related macular degeneration • choroid: neovascularization • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×